Childhood Cancer

You are here

Home » Grants » All grants tagged with "Solid and Bone Cancers"

All grants tagged with "Solid and Bone Cancers"

Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy
Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD
University of Wisconsin - Madison
Innovation Grants, Awarded 2022
Targeted nanoparticle-mediated “cold”-to-“hot” reprogramming of the tumor microenvironment of high-risk neuroblastoma
Prabhani Atukorale, PhD & Jason Shohet, MD, PhD
University of Massachusetts Amherst, University of Massachusetts Chan Medical School
Innovation Grants, Awarded 2022
Impact of STAG2 loss on DNA Damage and Immunobiology in Ewing sarcoma
Kelly Bailey, MD, PhD
University of Pittsburgh
Innovation Grants, Awarded 2022
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma
Michelle Monje
Board of Trustees of the Leland Stanford Junior University
Catalyst Grants, Awarded 2021
Determining the role of Ewing sarcoma derived extracellular vesicles in reprogramming of the tumor microenvironment
Andy Jia
BC Cancer (Provincial Health Services Authority)
POST Program Grants, Awarded 2022
Patterns of Ewing sarcoma metastases in a zebrafish human xenograft model
Jennifer Stiene
Cleveland Clinic Foundation
POST Program Grants, Awarded 2022
Protecting "off-the-shelf" NK cell therapies from rejection
Victoria DeBrock
Baylor College of Medicine
POST Program Grants, Awarded 2022
Development of targeted combination therapies for rhabdoid tumor
Hannah Kim
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2022
Selectively targeting EP300 with small molecule inhibitors for neuroblastoma therapy
Bozhao Li
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2022
Preclinical differentiation/chemotherapy combination treatment in stage IV neuroblastoma
Elizabeth Kappil
University of Texas at Austin
POST Program Grants, Awarded 2022

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »